MYC Antibody - N-terminal region

Catalog Number: ASB-ARP32708_P050
Article Name: MYC Antibody - N-terminal region
Biozol Catalog Number: ASB-ARP32708_P050
Supplier Catalog Number: ARP32708_P050
Alternative Catalog Number: ASB-ARP32708_P050-25UL,ASB-ARP32708_P050-100UL
Manufacturer: Aviva
Host: Rabbit
Category: Proteine/Peptide
Application: IHC, WB
Species Reactivity: Bovine, Canine, Equine, Guinea pig, Human, Mouse, Rabbit, Rat, Sheep
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human MYC
Alternative Names: MRTL, MYCC, c-Myc, bHLHe39
MYC is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this MYC gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma.The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitts lymphomas, suggesting its importance in the normal function of this gene.The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitts lymphomas, suggesting its importance in the normal function of this gene.
Clonality: Polyclonal
Concentration: 0.5 mg/ml
Molecular Weight: 50kDa
NCBI: 4609
UniProt: P01106
Form: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Human Muscle
WB Suggested Anti-MYC Antibody Titration: 0.0625ug/ml
Positive Control: Transfected 293T
Host: Mouse
Target Name: MYC
Sample Tissue: Mouse Kidney
Antibody Dilution: 1ug/ml
MYC antibody - N-terminal region (ARP32708_P050) in Transfected 293T using Western Blot